Abstract:A series of C-5 modified 3-iodo-4-aryloxypyridinones (IOPY's) and 3-iodo-4-arylthiopyridinones (ISPY's) serves as a potential class of HIV-1 non-nucleoside reverse transcriptase inhibitors. These two pyridinone analogues are attracting more attentions mainly due to their potential abilities to simultaneously inhibit wild type and mutant HIV-1 strains. In this study, two sets of traditional two-dimensional descriptors were applied respectively to create linear and binary QSAR models for these compounds. Our results indicated the well prediction ability of the obtained models. It is also indicated that binary model achieved a better prediction results than the linear one. Furthermore, in order to obtain a better description of the structure characteristics of the HIV-1 reverse transcriptase inhibitors, 3D-QSAR models and SAReport analysis were used to explore the compound features which contribute to the inhibition of wild type as well as mutant HIV-1 strains. Our analysis reveals that there may existed three principles to follow when the compounds are modified: (i) the electrostatic potentials distribution of R-groups plays a key role in determining the biological activities of the compounds; (ii) an aromatic ring or aromatic heterocycle for R-groups is favorable to enhance the biological activity; and finally (iii) the number of substituents attached to the ring of R-groups should be appropriate.

QSAR Models for 2-Amino-6-arylsulfonylbenzonitriles and Congeners HIV-1 Reverse Transcriptase Inhibitors Based on Linear and Nonlinear Regression Methods.

QSAR Studies on 1-Aryl-tetrahydroisoquinoline Analogs As Active Anti-HIV Agents Based on PSO-v-SVM

Multi-target QSAR study in the analysis and design of HIV-1 inhibitors

Quantitative Structure-Activity Relationship Study of the Non-Nucleoside Inhibitors of HCV NS5B Polymerase by Machine Learning Methods

QSAR Study of Carboxylic Acid Derivatives As HIV-1 Integrase Inhibitors

2D-Qsars of 1-Alkoxymethyl-5-alkyl-6-naphthytmethyl Uracills As Hept Analogues with Anti-Hiv-1 Activity

Receptor- and Ligand-Based 3D-QSAR Study for a Series of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors.

Quantitative Structure-Activity Relationship of IOPY/ISPY Analogues as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

Qsar Studies of Hept Derivatives As Anti-Hiv Drugs Using the Rasms Method

3D-QSAR for HIV-1 reverse transcriptase inhibitors

QSAR Studies of HEPT Derivatives As HIV-1 Reverse Transcriptase Inhibitors Using Physicochemical Parameters of Substituents

QSAR studies of HETP anti-HIV drug using three-dimensional holographic vector of atomic interaction field (3D-HoVAIF)

Applications of Genetic Algorithms on the Structure–activity Correlation Study of a Group of Non-Nucleoside HIV-1 Inhibitors

Quantitatives Structure-Activity Relationship and Modification of HIV Protease Inhibitors

Simple and Accurate Approaches to Predict the Activity of Benzothiadiazine Derivatives As HCV Inhibitors

Prediction of CCR5 Receptor Binding Affinity of Substituted 1-(3,3-diphenylpropyl)-piperidinyl Amides and Ureas Based on the Heuristic Method, Support Vector Machine and Projection Pursuit Regression.

Comparative Study of Qsar/Qspr Correlations Using Support Vector Machines, Radial Basis Function Neural Networks, and Multiple Linear Regression

QSAR Studies of Anti-HIV Drug HEPT Using 3D-Hovaif

QSAR Studies on 6-（1-naphthylmethyl） Substituted S-DABO Derivatives As Novel Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors

QSAR study on quinolone carboxylic acids as HIV-1 integrase inhibitors based on GEPMS algorithm

3D-QSAR Analysis of a Series of S-DABO Derivatives As Anti-Hiv Agents by CoMFA and CoMSIA